US Capitol Capsule: Consortia tide rising: Does it float your boat?
This article was originally published in Scrip
Executive Summary
Biopharmaceutical makers, academic institutions, patient groups and government agencies facing complex scientific, regulatory or other challenges whose solutions are beyond the reach of a single entity can benefit by leveraging and aggregating their intellect and resources through participating in public-private consortia – partnerships that provides neutral and temporary collaborative environments for oftentimes competing organizations.